ApprovalTrail

Approval · Notice of Compliance 35384 · 2025

FML: Notice of Compliance 35384

Issued May 20, 2025

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
35384
Date
May 20, 2025
Company
AbbVie CorporationSaint-Laurent, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Change in the drug product manufacturing process

Products in this notice

BrandDINStatus today
FMLNot yet assigned—

Medicinal ingredients